Movement Alert｜Hims & Hers Health Inc. Intraday Rise 6.16% in Regular Trading, Earnings Preview Supports Sentiment Despite Ongoing FTC Overhang

Market Focus11-04 23:23

On November 4, Hims & Hers Health Inc. rose 6.16% in Regular Trading, trading at $27.735/share, with turnover of $134 million.

The clearest catalyst in public information was a shift in focus toward the company’s upcoming earnings report due November 9, with consensus expecting quarterly revenue of $893 million, up 53.88% year over year, and EPS of $0.06 to $0.07, helping offset near-term pressure from the FTC complaint and subscription-billing controversy.

Supporting context shows the company previously guided third-quarter revenue to $880 million-$900 million after second-quarter revenue reached $753 million, up 38.25% year over year. At the same time, investors continue to monitor weaker profitability trends, including margin pressure tied to international expansion and weight-management products, as well as the company’s effort to dismiss the FTC complaint.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment